Sonova (OTCMKTS:SONVY) Stock Rating Lowered by Barclays

Sonova (OTCMKTS:SONVY - Get Free Report) was downgraded by stock analysts at Barclays from a "strong-buy" rating to a "hold" rating in a note issued to investors on Wednesday,Zacks.com reports.

A number of other equities analysts also recently weighed in on SONVY. UBS Group raised shares of Sonova to a "hold" rating in a research note on Tuesday, August 13th. The Goldman Sachs Group upgraded Sonova to a "strong sell" rating in a research note on Tuesday, October 22nd.

Sonova Stock Up 1.6 %

Shares of SONVY stock traded up $1.13 during trading on Wednesday, hitting $69.75. 18,248 shares of the company were exchanged, compared to its average volume of 18,587. The company has a debt-to-equity ratio of 0.63, a quick ratio of 1.07 and a current ratio of 1.45. The business's 50-day simple moving average is $72.40 and its 200 day simple moving average is $66.84. Sonova has a twelve month low of $54.18 and a twelve month high of $77.56.

Sonova Company Profile

Sonova Holding AG manufactures and sells hearing care solutions for adults and children in the United States, Europe, the Middle East, Africa, and the Asia Pacific. It operates through two segments, Hearing Instruments and Cochlear Implants segments. The Hearing Instruments segments engages in the design, development, manufacture, distribution, and service of hearing instruments and related products, as well as wireless headsets, speech-enhanced hearables, and audiophile headphones under the Phonak, Unitron, Hansaton, and Sennheiser brand names; and audiological care services under the AudioNova, Audium, Audition Santé, Boots Hearingcare, Connect Hearing, Geers, Hansaton, Lapperre, Schoonenberg, and Triton Hearing brands.